New Data Across Pfizer Inc.’s Pain and Inflammation Portfolio to Be Presented at Upcoming American College of Rheumatology Meeting

NEW YORK--(BUSINESS WIRE)--Pfizer will highlight several presentations and posters across a spectrum of pain and inflammatory conditions at the American College of Rheumatology (ACR) annual meeting in San Francisco from October 25 to 29, 2008. Late-breaking abstracts for Pfizer’s investigational JAK-inhibitor CP-690,550 and Celebrex (celecoxib capsules) will be presented at the meeting.
MORE ON THIS TOPIC